High nuclear p27kip1 levels predicts sensitivity to neoadjuvant letrozole in ER plus breast cancer independent of pAKT levels, PIK3CA mutation status and cell cycle effects:: a potential role for p27kip1 in predicting enhanced autophagocytosis in response to aromatase inhibitor therapy.

被引：0
|
作者：
Ellis, M. J.
Tao, Y.
Lin, L.
Evans, D. B.
Miller, W. R.
Weber, J.
DeSchryver, K.
Crowder, R.
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Univ Edinburgh, Edinburgh, Midlothian, Scotland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S187 / S187
页数：1
相关论文
共 3 条
  • [1] Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
    Charles Catzavelos
    Nandita Bhattacharya
    Yee C. Ung
    James A. Wilson
    Luba Roncari
    Charanjit Sandhu
    Patricia Shaw
    Herman Yeger
    Isabella Morava-Protzner
    Linda Kapusta
    Edmée Franssen
    Kathleen I. Pritchard
    Joyce M. Slingerland
    Nature Medicine, 1997, 3 : 227 - 230
  • [2] Pathological and biological (Ki-67 and p27KIP1 expression) effects of neoadjuvant aromatase inhibitor therapy for breast cancer patients
    Oba, H.
    Kurosumi, M.
    Ninomiya, J.
    Yoshida, T.
    Takei, H.
    Inoue, K.
    Tabei, T.
    VIRCHOWS ARCHIV, 2009, 455 : 182 - 182
  • [3] Low levels of cell cycle inhibitor p27kip1 combined with high levels of Ki-67 predict shortened disease-free survival in T1 and T2 invasive breast carcinomas
    Lau, R
    Grimson, R
    Sansome, C
    Tornos, C
    Moll, UM
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (01) : 17 - 23
1